Changes are afoot to meet higher caseloads amid rising demand, the survey of 6,830 cardiovascular providers suggests.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.